SCHEMBL7608607

SCHEMBL7608607

OC1CCCCC1n1c(NC2CC2)nc2cc(Cl)c(Cl)cc21

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 2/20 0.46
CDK9 P50750 2/20 0.46
HDAC6 Q9UBN7 1/20 0.39
PRPS1 P60891 3/20 0.36
KMT5B Q4FZB7 1/20 0.36
KMT5C Q86Y97 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.33
MAPK10 P53779 1/20 0.32
MAPK14 Q16539 1/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
SOS1 Q07889 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
HTR2A P28223 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
SLC6A4 P31645 1/20 0.32
OPRK1 P41145 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7608598 1.00 CCNT1 (0.46) CCNT1CDK9HDAC6PRPS1KMT5B
SCHEMBL7608602 1.00 CCNT1 (0.46) CCNT1CDK9HDAC6PRPS1KMT5B
SCHEMBL7608609 0.90 CCNT1 (0.41) CCNT1CDK9HDAC6PRPS1KMT5B
SCHEMBL7608610 0.90 CCNT1 (0.41) CCNT1CDK9HDAC6PRPS1KMT5B
SCHEMBL8795672 0.81 HDAC6 (0.40) CCNT1CDK9HDAC6PRPS1IRAK4
SCHEMBL8795674 0.81 HDAC6 (0.40) CCNT1CDK9HDAC6PRPS1IRAK4
SCHEMBL8794070 0.81 CCNT1 (0.40) CCNT1CDK9HDAC6IRAK4MAPK14
SCHEMBL8794075 0.81 CCNT1 (0.40) CCNT1CDK9HDAC6IRAK4MAPK14
SCHEMBL9062629 0.79 HDAC6 (0.43) CCNT1CDK9HDAC6KMT5BKMT5C
SCHEMBL9062625 0.79 HDAC6 (0.43) CCNT1CDK9HDAC6KMT5BKMT5C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455507-B1 E.G., 2-BROMO-5,6-DICHLORO-1-BETA-D-RIBOPYRANOSYL-1H-BENZIMIDAZOLE; VIRICIDES, ESPECIALLY INFECTIONS OF HERPES AND CYTOMEGALO VIRUSES SMITHKLINE BEECHAM CORPORATION 2002-09-24 US disclosed
US-20020094963-A1 BENZIMIDAZOLE DERIVATIVES GLAXO WELLCOME INC. 2002-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094963-A1 BENZIMIDAZOLE DERIVATIVES ZC3HAV1, BRPF3, BRD3 CCNT1 483/4885CDK9 138/4885HDAC6 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.